Pyc Therapeutics Ltd has released a press release.
March 2019 Quarterly Operational Update and App4C
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
Story so far
Earlier from PYC Therapeutics
- Collaboration Agreement - siRNA delivery
- Flagship Program - Successful Animal Models
- First Competitive Read Out - Peptide Vaccine
- Dec 2018 Operational Update and App4C
- CEO letter and Operational Update
Later from PYC Therapeutics
- Break Through Animal Model Results
- Animal Models - 400% Outperformance of Gold Standard
- Operational Update and Appendix 4C
- Company Presentation - July 2019
- Phylogicas Technology is Effective in Human Cells
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics